ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163664 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163664; 2) Community: the network communities that were significantly associated with the response to NSC 163664; 3) Molecule: the relationships between components within communities and NSC 163664; 4) MDR: the compounds that were significantly associated with the NSC 163664.

NSC Compound Enrichment Correlation
NSC 735333 Null 0.00645628049634952 0.41782264
NSC 754240 2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one 0.00645628049634952 0.038540247
NSC 94037 Mikanolide 0.00645628049634952 0.5190254
NSC 100290 Doxypyrromycin hydrochloride 0.00645628049634956 0.18137603
NSC 15812 Null 0.00645628049634956 0.4140578
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.00862782236704185 0.1608372
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.00862782236704185 0.63296767
NSC 164970 Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- 0.00862782236704185 0.322136
NSC 166199 Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) 0.00862782236704185 0.00032462193
NSC 618770 Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide 0.00862782236704185 0.5048969
Total:126  Current:33    [First] [Prev] [Next] [Last]